Average Co-Inventor Count = 4.33
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (50 from 3,923 patents)
50 patents:
1. 12226405 - Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
2. 11229643 - Combinations of FGFR4 inhibitors and bile acid sequestrants
3. 10786492 - Formylated N-heterocyclic derivatives as FGFR4 inhibitors
4. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
5. 10251868 - Benzothiazolone compound
6. 10202371 - Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors
7. 10189813 - Formylated N-heterocyclic derivatives as FGFR4 inhibitors
8. 10130629 - Pharmaceutical combinations
9. 9913828 - Benzothiazolone compound
10. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
11. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
12. 9623012 - Formulation comprising benzothiazolone compound
13. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
14. 9458177 - Oxazolidin-2-one compounds and uses thereof
15. 9296733 - Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases